Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Symbiosis00:58

Symbiosis

37.9K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
37.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).

Arthritis research & therapy·2026
Same author

Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS).

Modern rheumatology·2026
Same author

Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS.

International journal of rheumatic diseases·2026
Same author

Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS).

Clinical and experimental rheumatology·2025
Same author

Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS).

Rheumatology international·2025
Same author

Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2025
Same journal

Efficacy of artemether-lumefantrine combination for the treatment of uncomplicated Plasmodium falciparum malaria after 16 years of its introduction into Ghana's antimalarial medicines policy.

Malaria journal·2026
Same journal

Healthcare utilization patterns and diagnostic delays among international migrant workers with imported malaria in China: a retrospective cohort analysis.

Malaria journal·2026
Same journal

Genotypic analysis of Plasmodium falciparum malaria parasites in a clinical trial of RTS,S vaccination in combination with seasonal malaria chemoprevention.

Malaria journal·2026
Same journal

Less is more: modelling the impact of species-targeted versus broadcast larviciding in Anopheles funestus-dominated malaria transmission settings.

Malaria journal·2026
Same journal

'Poverty is the biggest barrier': stakeholder perspectives on social determinants of malaria in Wakiso District, Uganda.

Malaria journal·2026
Same journal

Clinical malaria recurrence and associated factors in infancy following IPTp-DP versus IPTp-SP in Busia, Uganda; a secondary analysis using the Conditional Frailty model.

Malaria journal·2026
See all related articles

Related Experiment Video

Updated: Mar 3, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

588

Ivermectin and malaria control.

Satoshi Ōmura1, Andy Crump2

  • 1Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.

Malaria Journal
|April 26, 2017
PubMed
Summary
This summary is machine-generated.

Ivermectin shows promise as a novel tool for malaria elimination by targeting mosquito vectors. Further research into ivermectin analogues could enhance its efficacy against malaria and neglected tropical diseases (NTDs).

Keywords:
Feed-through insecticideIvermectinMalaria

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.8K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 3, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

588
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.8K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.7K

Area of Science:

  • Medical Entomology
  • Parasitology
  • Drug Discovery

Background:

  • Global efforts are underway to eliminate malaria, requiring innovative tools and integrated interventions for the final stages.
  • Ivermectin has successfully reduced the burden of neglected tropical diseases (NTDs) and offers non-target benefits, including parasite and insecticidal properties.
  • Ivermectin's known efficacy against Anopheles mosquitoes, the vectors of malaria, presents an opportunity for repurposing.

Purpose of the Study:

  • To explore the potential of reformulating ivermectin as a feed-through mosquitocidal agent for malaria elimination.
  • To assess ivermectin's broader impact on combating malaria and other NTDs in co-infected communities.
  • To investigate ivermectin analogues and parent avermectin compounds for enhanced efficacy and targeted activity.

Main Methods:

  • Review of existing data on ivermectin's efficacy against parasites, insects, and its safety profile in mass drug administration (MDA) programs.
  • Analysis of ivermectin's chemical composition and the specific activity of its component compounds.
  • Proposed structure-activity relationship studies for ivermectin analogues and avermectin compounds.

Main Results:

  • Ivermectin demonstrates broad-spectrum activity against parasites and insects, including malaria vectors.
  • The drug is proven safe for human use, facilitating widespread application.
  • Preliminary findings suggest only a minor component of ivermectin possesses molluscicidal activity, indicating potential for targeted analogue development.

Conclusions:

  • Repurposing ivermectin as a mosquitocide is a promising strategy for malaria control and elimination.
  • Further research into ivermectin analogues could yield more potent and specific agents for tackling malaria and NTDs simultaneously.
  • Ivermectin's established safety and non-target benefits make it a valuable tool for integrated disease control programs.